Exposing infants to alcohol through breastfeeding may reduce their cognitive ability at age 6 to 7 years.
The researchers investigated whether the potential relationship between pregnancy and AD risk was linked to an immunologic mechanism.
For more details about differences in stroke risk, prevention, and treatment in women, Neurology Advisor spoke with Elisabeth B. Marsh, MD, from Johns Hopkins School of Medicine and Kristy Yuan, MD, from the University of Pennsylvania.
Antihypertensive treatments during delivery hospitalizations in women with preeclampsia have increased.
Researchers have observed an upward trend in the incidence of pregnancy-related spontaneous subarachnoid hemorrhage.
The findings emphasize the importance of seizure control before pregnancy in women with epilepsy.
Although unplanned, women with epilepsy were very likely to take required prenatal vitamins.
Among infants exposed to the medication in utero, none had major or significant malformations.
The findings suggest the importance of screening for posttraumatic stress disorder in this population.
Previous research has shown a reduced risk for multiple sclerosis and relapse during pregnancy.
Antidepressant use before conception was associated with a higher risk of autism spectrum disorders compared with antidepressant use during pregnancy.
Previous research has suggested a link between early use of pregabalin in pregnancy and congenital malformations.
Mortality among women with preeclampsia and pregnancy-associated stroke was significantly higher than in controls.
Women with higher body mass index were associated with children with a greater epilepsy incidence.
Lamotrigine and carbamazepine may represent safer treatment alternatives for girls and women who are or who might become pregnant.
While their are other factors more strongly associated with risk of cerebral palsy, maternal obesity is modifiable and therefore should be studied further.
The CDC report only accounts for physical birth defects, as researchers note that the full scope of developmental defects has yet to be recorded.
Patients taking enzyme-inducing antiepileptic drugs and hormonal contraceptives face a greater risk of unintended pregnancy.
Migraine in pregnancy may warrant early referral to a neurologist and more intensive surveillance as a result of increased adverse birth events.
The review found that there is substantial evidence that supports folic acid supplementation during pregnancy.
Women who were pregnant and slept for less than 6 hours per night or had poor sleep quality had a greater risk of developing gestational diabetes.
Among study participants, relapse rate actually decreased from the first to second pregnancy.
Women who had high blood pressure while pregnant demonstrated later cognitive impairment and smaller brain volume compared with women who had normotensive pregnancies.
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Early Clinical Traits of Multiple Sclerosis Prodrome Identified
- Chronic Pain May Be Contributor to Suicide
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- Ajovy Injection Approved for Migraine Prevention in Adults
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies
- Familial Hemiplegic Migraine Attacks May Be Associated With Cortical Swelling
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine
- Propofol May Decrease Delay in Neurocognitive Recovery